COVID associated with hearing loss, tinnitus and vertigo – new study confirms link
COVID associated with hearing loss, tinnitus and vertigo – new study confirms link – The Conversation Original study: One year on: an updated systematic review of SARS-CoV-2, COVID-19 and audio-vestibular symptoms – International Journal of Audiology
The post COVID associated with hearing loss, tinnitus and vertigo – new study confirms link appeared first on Links Medicus.
RCT: Discontinuing β-lactam treatment after 3 days as good as 8 days of treatment for stable patients with community-acquired pneumonia in non-critical care wards
Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial – The Lancet Commentary on Twitter Less can be more for pneumonia. In 50% CAP patients was possible stop Abx at 3 days and outcomes were the same @TheLancet https://t.co/Hc1AxyndWS pic.twitter.com/Ypk2uXeDQV — […]
The post RCT: Discontinuing β-lactam treatment after 3 days as good as 8 days of treatment for stable patients with community-acquired pneumonia in non-critical care wards appeared first on Links Medicus.
Interleukin‐6 blocking agents for treating COVID‐19: a living systematic review
Interleukin‐6 blocking agents for treating COVID‐19: a living systematic review – Cochrane Library Commentary on Twitter JUST PUBLISHED – Interleukin‐6 blocking agents for treating #COVID19 https://t.co/pt8BNfBwa3 New living systematic review from @Cochrane_ACE looks at the evidence from 10 studies in 6896 people with COVID‐19 pic.twitter.com/hjs97lPBEt — Cochrane UK (@CochraneUK) March 26, 2021
The post Interleukin‐6 blocking agents for treating COVID‐19: a living systematic review appeared first on Links Medicus.
Opinion | COVID-19 Is Different Now: The coronavirus is changing. So is the disease it causes.
COVID-19 Is Different Now – The Atlantic
The post Opinion | COVID-19 Is Different Now: The coronavirus is changing. So is the disease it causes. appeared first on Links Medicus.
Opinion | The Coronavirus Variants Don’t Seem to Be Highly Variable So Far
The Coronavirus Variants Don’t Seem to Be Highly Variable So Far – Scientific American
The post Opinion | The Coronavirus Variants Don’t Seem to Be Highly Variable So Far appeared first on Links Medicus.
Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 “long haulers”
Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 “long haulers” – Annals of Clinical and Translational Neurology Commentary: 85% of COVID-19 long-haulers have multiple brain-related symptoms – LiveScience AND ‘Brain fog’ and other neurologic symptoms can last for months after Covid – NBC News AND Neurologic Symptoms Persistent for Many COVID-19 ‘Long-Haulers’ – Health […]
The post Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 “long haulers” appeared first on Links Medicus.
Covid-19: Middle aged women face greater risk of debilitating long term symptoms
Covid-19: Middle aged women face greater risk of debilitating long term symptoms – The BMJ Linked Opinion: The stigma is real for people living with long covid – The BMJ Opinion
The post Covid-19: Middle aged women face greater risk of debilitating long term symptoms appeared first on Links Medicus.
How COVID-19 Affects the Brain
How COVID-19 Affects the Brain – JAMA Psychiatry Commentary on Twitter #COVID19 brain symptoms are a rising concern. Mechanisms of brain damage by the virus include lasting neuroinflammation, thrombotic events and alteration of neurotransmitters release. Consequently, people suffer cognitive, emotional and behavioral symptoms https://t.co/pTzJo6DLV8 — JAMA Psychiatry (@JAMAPsych) March 26, 2021
The post How COVID-19 Affects the Brain appeared first on Links Medicus.
Another study indicates SARS-CoV-2 variant B.1.351, but not variant B.1.1.7, has partial resistance to neutralizing antibodies generated by natural infection or mRNA vaccination
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies – Nature Medicine Commentaries on Twitter Now a peer-reviewed pub in a top journal, this elegant study clearly shows that variant B.1.351 isn't stopped by antibodies from prior infection or the Pfizer vax. We'll have revised vaccines, but we don't yet. Please behave […]
The post Another study indicates SARS-CoV-2 variant B.1.351, but not variant B.1.1.7, has partial resistance to neutralizing antibodies generated by natural infection or mRNA vaccination appeared first on Links Medicus.
Cochrane Library Editorial: Contested effects and chaotic policies: the 2020 story of (hydroxy) chloroquine for treating COVID‐19
Contested effects and chaotic policies: the 2020 story of (hydroxy) chloroquine for treating COVID‐19 – Cochrane Library Commentary and Infographic: Is chloroquine or hydroxychloroquine useful in treating people with COVID-19, or in preventing infection in people who have been exposed to the virus? – Cochrane Library Original review: Chloroquine or hydroxychloroquine for prevention and treatment […]
The post Cochrane Library Editorial: Contested effects and chaotic policies: the 2020 story of (hydroxy) chloroquine for treating COVID‐19 appeared first on Links Medicus.